Gain Therapeutics (GANX) Change in Account Payables (2021 - 2022)
Gain Therapeutics (GANX) posted quarterly Change in Account Payables of $1.5 million for Q1 2022, up 1761.8% year-over-year from $82927.0 in Q1 2021, and up 1761.8% quarter-over-quarter from $82927.0 in Q1 2021.
Gain Therapeutics (GANX) Change in Account Payables (2021 - 2022) Analysis & Trends
Gain Therapeutics' Change in Account Payables history runs 2 years deep, the most recent figure standing at $1.5 million for Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -8.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 37.53 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Gain Therapeutics | 85.97 Mn | 85.97 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 1.54 Mn |
| Mar 31, 2022 | 1.54 Mn |
| Mar 31, 2021 | 82,927.00 |
| Mar 31, 2021 | 82,927.00 |